Blincyto (Blinatumomab) Side Effects: What You Need to Know

Understanding Blincyto (Blinatumomab) Side Effects Blincyto, also known by its generic name blinatumomab, is a powerful prescription medication used to treat certain types of acute lymphoblastic leukemia (ALL) in both adults and children. It is administered intravenously (IV) by a healthcare professional. While Blincyto is an effective treatment, like all medications, it can cause side effects. These can range from mild to severe, and it's crucial for patients and their caregivers to be aware of them. This article provides a comprehensive overview of the potential side effects of Blincyto, focusing on common, mild, and serious reactions, with particular attention to neurotoxicity and cytokine release syndrome (CRS), which carry boxed warnings from the FDA. What are the Common Side Effects of Blincyto? Several side effects are frequently reported in individuals undergoing Blincyto treatment. These can include: Fever Infusion-related reactions Headache Nausea Low white blood cell count (neutropenia) Low platelet count (thrombocytopenia) Low red blood cell count (anemia) Tremor Dizziness Fatigue Decreased appetite Constipation Diarrhea Rash Cough Mouth sores (stomatitis) Swelling in arms or legs Increased liver enzymes Increased creatinine levels Many of these common side effects are manageable and may be temporary. However, it is essential to discuss any persistent or bothersome symptoms with your doctor. Mild Side Effects of Blincyto Blincyto can also cause milder side effects that, while not life-threatening, can impact your quality of life during treatment. These may include: Low levels of red blood cells or platelets General feelings of being unwell Changes in taste Muscle or joint pain Difficulty sleeping Dry mouth Indigestion Hair loss Increased blood pressure Shortness of breath Chills Back pain Pain in extremities Nausea and vomiting Abdominal pain Weight gain Changes in blood sugar levels Changes in electrolyte levels Increased risk of infections In most instances, these mild side effects are temporary and can be effectively managed. If you experience any symptoms that are concerning or do not resolve, consult your healthcare provider. It is important not to stop Blincyto treatment without your doctor's explicit recommendation. Serious Side Effects Explained Blincyto carries significant boxed warnings due to the risk of serious side effects, namely neurotoxicity and cytokine release syndrome (CRS). These require immediate medical attention. Neurotoxicity Neurotoxicity refers to damage to the nervous system. In studies, mild neurotoxicity was a common side effect in patients receiving Blincyto. It is most likely to occur within the first two weeks of starting treatment but can manifest at any point during therapy. Symptoms of neurotoxicity may include: Headache Dizziness Tremors Confusion Difficulty speaking Seizures Changes in mental status Loss of coordination Weakness in limbs Numbness or tingling What to do: If you experience symptoms of neurotoxicity at home between doses, contact your doctor immediately. If your symptoms seem life-threatening or you believe you are experiencing a medical emergency, call 911 or your local emergency number without delay. Cytokine Release Syndrome (CRS) Cytokine Release Syndrome (CRS) is a potentially severe systemic inflammatory response that can occur when the immune system becomes overactivated. CRS is most likely to occur within the first 2 to 5 days of receiving Blincyto, though it can happen at any time. Symptoms of CRS may include: High fever Chills Rapid heart rate Low blood pressure Difficulty breathing Nausea and vomiting Diarrhea Headache Rash Confusion Seizures What to do: If you experience symptoms of CRS, seek immediate medical attention by calling 911 or your local emergency number. Prompt treatment is crucial to manage CRS effectively. Infusion-Related Reactions An infusion-related reaction can occur during or shortly after an intravenous (IV) infusion of Blincyto. These reactions can happen during the infusion or within 48 hours afterward. Symptoms may include: Fever Chills Nausea Vomiting Headache Rash Shortness of breath Low blood pressure If an infusion-related reaction lasts for more than 14 days, your doctor may consider permanently stopping your Blincyto treatment. Severe Allergic Reactions Although rare, severe allergic reactions can occur. Symptoms may include swelling of the face, lips, tongue, or throat, and difficulty breathing. What to do: If you experience symptoms of a severe allergic reaction, call 911 or your local emergency number immediately. These symptoms can be life-threatening and require urgent medical care. Important Considerations During Treatment Pregnancy and Breastfeeding Blincyto can harm a developing fetus. If you are able to become pregnant, your doctor will perform a pregnancy test before you start treatment. You must use effective birth control during Blincyto treatment and for at least 48 hours after your last dose. It is not known if Blincyto passes into breast milk. Therefore, you should not breastfeed during treatment or for 48 hours after your last dose due to the potential risk of harm to an infant. When to Consult a Doctor It is vital to maintain open communication with your healthcare team. You should contact your doctor immediately if you experience: Any new or worsening symptoms of neurotoxicity or CRS. Symptoms of a severe allergic reaction. Any side effect that is persistent, severe, or concerning. Signs of infection, such as fever, chills, or sore throat. Emergency Situations: If your side effects seem life-threatening or you believe you are experiencing a medical emergency, do not hesitate to call 911 or your local emergency number immediately. Managing Side Effects Your healthcare provider will monitor you closely for side effects during Blincyto treatment. They may adjust your dosage, temporarily stop treatment, or provide supportive care to manage side effects. This can include medications to manage

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.